Stockreport

Seres Therapeutics Announces FDA Orphan Drug Designation for SER-287 in Treatment of Pediatric Ulcerative Colitis

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Seres Therapeutics, Inc., (NASDAQ:MCRB) today announced that the U.S. Food and Drug Administration (FDA) has grant [Read more]